Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole Efficacy and Safety in Primary Restless Legs Syndrome
NCT00152997Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pramipexole in restless legs syndrome (RLS), sponsored by Boehringer Ingelheim. Started Aug 2004; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00152997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152997.